郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Identification of a second blocker binding site at the cytoplasmic mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore.

期刊：Molecular pharmacology发表年份：2007作者：Chantal N St Aubin; Jing-Jun Zhou; Paul Linsdell
阅读更多 →

药效评价Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.

期刊：Journal of neurochemistry发表年份：2007作者：Francesca Novi; Mark J Millan; Giovanni U Corsini; Roberto Maggio
阅读更多 →

药效评价Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.

期刊：Biochemical pharmacology发表年份：2007作者：Michiaki Nagasawa; Yunike Akasaka; Tomohiro Ide; Tomoko Hara; Naoki Kobayashi; Mari Utsumi; Koji Murakami
阅读更多 →

药效评价Upregulation of acid-sensing ion channel ASIC1a in spinal dorsal horn neurons contributes to inflammatory pain hypersensitivity.

期刊：The Journal of neuroscience : the official journal of the Society for Neuroscience发表年份：2007作者：Bo Duan; Long-Jun Wu; Yao-Qing Yu; Yu Ding; Liang Jing; Lin Xu; Jun Chen; Tian-Le Xu
阅读更多 →